Bluejay Diagnostics Inc

General ticker "BJDX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $39.6M

Bluejay Diagnostics Inc does not follow the US Stock Market performance with the rate: -42.4%.

Estimated limits based on current volatility of 7.0%: low 3.55$, high 4.09$

Factors to consider:

  • Current price 97.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [159.95$, 984.66$]
  • 2024-12-30 to 2025-12-30 estimated range: [39.29$, 240.92$]

Financial Metrics affecting the BJDX estimates:

  • Negative: Non-GAAP EPS, $ of -21.47 <= 0.10
  • Negative: negative Net income
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -4.68 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85

Similar symbols

Short-term BJDX quotes

Long-term BJDX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.25MM $0.00MM
Operating Expenses $3.23MM $9.57MM $10.31MM
Operating Income $-3.23MM $-9.32MM $-10.31MM
Non-Operating Income $-0.26MM $0.02MM $0.36MM
Interest Expense $0.37MM $0.00MM $0.00MM
R&D Expense $1.15MM $4.15MM $5.71MM
Income(Loss) $-3.49MM $-9.30MM $-9.95MM
Profit(Loss) $-3.49MM $-9.30MM $-9.95MM
Stockholders Equity $20.38MM $11.54MM $2.89MM
Assets $21.02MM $13.52MM $4.87MM
Operating Cash Flow $-4.37MM $-7.74MM $-8.31MM
Capital expenditure $0.02MM $1.20MM $0.70MM
Investing Cash Flow $-0.02MM $-1.20MM $-0.70MM
Financing Cash Flow $22.53MM $0.01MM $1.11MM
Earnings Per Share* $-29.67 $-73.22 $-72.62

* EPS are Split Adjusted, recent splits may be reflected with a delay.